FORA Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-68,482
Closed -$5.37M 556
2023
Q3
$5.37M Buy
+68,482
New +$5.73M 0.47% 53
2023
Q2
Sell
-40,220
Closed -$3.24M 506
2023
Q1
$3.24M Sell
40,220
-83,660
-68% -$6.82M 0.32% 95
2022
Q4
$9.63M Buy
+123,880
New +$10M 1.55% 5
2022
Q3
Sell
-38,566
Closed -$3.46M 500
2022
Q2
$3.46M Buy
+38,566
New +$3.91M 0.69% 30
2022
Q1
Sell
-12,772
Closed -$1.32M 584
2021
Q4
$1.32M Buy
+12,772
New +$1.48M 0.51% 47
2021
Q3
Sell
-10,161
Closed -$1.26M 660
2021
Q2
$1.26M Buy
+10,161
New +$1.28M 0.23% 110
2020
Q3
Sell
-7,894
Closed -$724K 854
2020
Q2
$724K Sell
7,894
-19,280
-71% -$1.85M 0.25% 100
2020
Q1
$2.45M Sell
27,174
-26,302
-49% -$2.8M 0.53% 31
2019
Q4
$6.07M Buy
+53,476
New +$5.87M 0.61% 25

Other funds holding MDT

FORA Capital's MDT Position: Q4 2023 in Review

FORA Capital sold out of Medtronic (MDT) in Q4 2023, closing a stake of 68,482 shares — an estimated $5.37M sold.

FORA Capital first reported a position in MDT in Q4 2019 and held it in 9 quarters. The position peaked at $9.63M in Q4 2022. 2,078 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

  • FORA Capital reported no remaining Medtronic position as of Q4 2023 after selling out during the quarter.
  • FORA Capital sold 68,482 Medtronic shares in Q4 2023, an estimated $5.37M.
  • FORA Capital first reported a position in Medtronic in Q4 2019 and held it in 9 quarters.
  • FORA Capital's Medtronic position peaked at $9.63M in Q4 2022.
  • 2,078 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on FORA Capital's 13F filing for Q4 2023, filed 14 Feb 2024.